propionylcarnitine has been researched along with Cardiovascular Diseases in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Lee, YH; Park, S | 1 |
Alvarez de Sotomayor, M; Herrera, MD; Justo, ML; Mingorance, C; RodrÃguez-RodrÃguez, R | 1 |
Malaguarnera, M | 1 |
Ceconi, C; Cicchitelli, G; Ferrari, R; Fucili, A; Mele, D; Merli, E | 1 |
Cauli, A; Iliceto, S; Lai, S; Mathieu, A; Meloni, L; Montisci, M; Montisci, R; Passiu, G; Ruscazio, M; Vacca, A | 1 |
3 review(s) available for propionylcarnitine and Cardiovascular Diseases
Article | Year |
---|---|
Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders.
Topics: Acetylcarnitine; Animals; Cardiovascular Agents; Cardiovascular Diseases; Carnitine; Diabetes Mellitus, Type 2; Evidence-Based Medicine; Humans; Hypoglycemic Agents; Insulin Resistance; Treatment Outcome | 2011 |
Carnitine derivatives: clinical usefulness.
Topics: Acetylcarnitine; Cardiotonic Agents; Cardiovascular Diseases; Carnitine; Cognition Disorders; Depression; Diabetes Mellitus; Humans; Liver Cirrhosis; Nervous System Diseases; Nootropic Agents | 2012 |
Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
Topics: Cardiotonic Agents; Cardiovascular Diseases; Carnitine; Humans; Kidney Failure, Chronic; Liver; Myocardial Ischemia; Valproic Acid | 2004 |
1 trial(s) available for propionylcarnitine and Cardiovascular Diseases
Article | Year |
---|---|
Effect of a single IV administration of L-propionylcarnitine on myocardial microcirculation assessed by coronary flow velocity reserve measurement in patients with systemic sclerosis: a pilot study.
Topics: Adenosine; Adult; Aged; Blood Flow Velocity; Cardiotonic Agents; Cardiovascular Diseases; Carnitine; Coronary Circulation; Coronary Vessels; Echocardiography, Doppler; Female; Humans; Injections, Intravenous; Male; Microcirculation; Middle Aged; Myocardium; Pilot Projects; Scleroderma, Systemic | 2007 |
1 other study(ies) available for propionylcarnitine and Cardiovascular Diseases
Article | Year |
---|---|
Genetic and Lifestyle-Related Factors Influencing Serum Hyper-Propionylcarnitine Concentrations and Their Association with Metabolic Syndrome and Cardiovascular Disease Risk.
Topics: Aged; Amino Acids; Cardiovascular Diseases; Carnitine; Genome-Wide Association Study; Humans; Kinesins; Life Style; Metabolic Syndrome; Middle Aged; Risk Factors | 2023 |